Cancer Research journals by time to acceptance (2025)
24 journals with 2025 figures · median days from submission to acceptance, measured from PubMed dates · data as of Sep 15, 2026
Sorted by median days from submission to acceptance in 2025. Faster is not better — this is a planning aid, not a ranking of quality. Click a column to re-sort.
| Open access | ||||||
|---|---|---|---|---|---|---|
| Cancer Genomics & Proteomics | 39 (30–52) | 72 | — | — | Open access | 0.0 |
| The Journal of Liquid Biopsy | 39 (29–50) | 50 | 3 | $2,080 | Open access (DOAJ) | — |
| Non-Coding RNA | 62 (49–81) | 77 | 4 | ≈$2,200 | Open access (DOAJ) | 0.0 |
| Molecular Cancer | 88 (57–131) | 301 | 29 | $5,290 | Open access (DOAJ) | 0.0 |
| The Breast | 93 (66–129) | 213 | 2 | $3,770 | Open access (DOAJ) | 0.0 |
| Journal of Cancer | 97 (73–133) | 246 | 21 | ≈$2,850 | Open access (DOAJ) | 0.92 |
| Journal of Experimental & Clinical Cancer Research | 101 (73–131) | 327 | 17 | $4,490 | Open access (DOAJ) | 5.19 |
| International Journal of Molecular Medicine | 104 (80–131) | 219 | 32 | — | Hybrid | 12.55 |
| Breast Cancer Targets and Therapy | 110 (85–142) | 107 | 13 | $4,320 | Open access (DOAJ) | 0.0 |
| Oncology Reports | 111 (91–142) | 132 | 38 | — | Hybrid | 11.26 |
| Non-coding RNA Research | 112 (84–152) | 93 | 2 | $1,100 | Open access (DOAJ) | 0.0 |
| Breast Cancer | 115 (78–153) | 139 | 13 | ≈$3,890 | — | 0.0 |
| OncoTargets and Therapy | 119 (98–150) | 95 | 12 | ≈$2,836 | Open access | 14.89 |
| Carcinogenesis | 121 (88–183) | 82 | — | ≈$4,835 | — | 2.21 |
| Oncology Letters | 125 (98–155) | 508 | 33 | — | Open access | 6.38 |
| Molecular Medicine Reports | 133 (105–163) | 306 | 38 | — | Hybrid | 10.8 |
| Experimental and Therapeutic Medicine | 133 (102–168) | 219 | 35 | — | Open access | 5.55 |
| Human Cell | 134 (83–189) | 160 | 15 | ≈$2,490 | — | 5.13 |
| Molecular Oncology | 153 (103–216) | 193 | 19 | $4,730 | Open access (DOAJ) | 1.02 |
| Open Medicine | 154 (107–213) | 197 | 57 | ≈$2,423 | Open access (DOAJ) | 8.51 |
| npj Breast Cancer | 155 (107–223) | 169 | 23 | $3,890 | Open access (DOAJ) | 0.0 |
| Journal of Cellular and Molecular Medicine | 162 (106–235) | 594 | — | $5,730 | Open access (DOAJ) | 1.66 |
| Cancer Cell International | 168 (113–243) | 503 | 19 | $3,290 | Open access (DOAJ) | 3.52 |
| Cancer Research | 233 (172–287) | 362 | — | — | Hybrid | 1.16 |
Journals are listed where at least 25% of their articles' topics fall in Cancer Research (OpenAlex).
Latest available year: 2024
3 journals without enough usable 2025 data. Their 2024 figures are shown separately so they are never compared with 2025 figures.
| Open access | ||||||
|---|---|---|---|---|---|---|
| Pathology & Oncology Research | 81 (52–120) | 66 | 15 | $2,500 | Open access (DOAJ) | 9.82 |
| Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics | 100 (80–132) | 152 | 156 | — | — | 0.0 |
| Neoplasma | 125 (77–173) | 51 | — | — | — | 0.0 |
Latest available year: 2022
2 journals without enough usable 2025 data. Their 2022 figures are shown separately so they are never compared with 2025 figures.
| Open access | ||||||
|---|---|---|---|---|---|---|
| Oncotarget | 55 (42–98) | 60 | 16 | — | Open access | 0.0 |
| Disease Markers | 68 (42–115) | 803 | 23 | ≈$2,550 | — | 105.18 |
Latest available year: 2021
1 journal without enough usable 2025 data. Their 2021 figures are shown separately so they are never compared with 2025 figures.
| Open access | ||||||
|---|---|---|---|---|---|---|
| Genes and Environment | 79 (58–112) | 58 | 20 | $2,590 | Open access (DOAJ) | — |
Latest available year: 2020
3 journals without enough usable 2025 data. Their 2020 figures are shown separately so they are never compared with 2025 figures.
| Open access | ||||||
|---|---|---|---|---|---|---|
| Cellular and Molecular Biology | 20 (10–141) | 183 | 31 | — | — | 0.0 |
| Journal of Breast Cancer | 96 (63–153) | 61 | — | $500 | Open access (DOAJ) | 0.0 |
| Environmental and Molecular Mutagenesis | 98 (63–132) | 54 | 21 | ≈$3,750 | — | 0.0 |
Have a deadline?
Pick up to five journals and see whether a submission sequence can realistically reach acceptance before your defence, visa or job-market date. Free.
Open the submission plannerFrequently asked questions
Which Cancer Research journals accepted papers fastest in 2025?
Among 24 Cancer Research journals with enough dated articles in 2025, the shortest median time from submission to acceptance was 39 days (Cancer Genomics & Proteomics). The middle journal's median was 119 days. Speed is not a measure of quality; check scope, indexing and fees too.
How are these times measured?
From the submission and acceptance dates publishers deposit in PubMed, for accepted articles only. Each journal needs at least 50 dated articles in the year shown, and a table headed with a year contains only that year's figures.
Get the free Journal Submission Go/No-Go Checklist
The pre-submission checks from Write and Publish a Scientific Paper: journal fit, formatting, cover letter and reviewer suggestions. We’ll email you the download link.
Data sources. Submission, acceptance and publication dates: Courtesy of the U.S. National Library of Medicine (PubMed, entries through Sep 15, 2026). NLM does not endorse Journal Clock, and these figures may not reflect the most current PubMed data. Journal fees and open-access listing: DOAJ (CC0, retrieved Sep 16, 2026). Fees paid by institutions: OpenAPC (Open Database License, retrieved Sep 16, 2026). Retractions: Retraction Watch Database via Crossref (retrieved Sep 16, 2026). Journal identifiers and topics: OpenAlex (CC0). Currency conversion: ECB reference rates (Sep 15, 2026). How these numbers are calculated · For organisations.